2016

Her scientific conclusions about the COVID-19 pandemic and the origins of the CCP (Chinese Communist Party) virus are ...

In this interview with internationally renowned Dr. Shankara Chetty from South Africa, we discuss the Omicron variant, which is taking the world as a storm. Is this variant to be feared, or could it actually be a positive development in this pandemic, as mostly inducing mild disease, yet conferring post-covid natural immunity. These are among the timely and critically important aspects we discuss. Dr. Chetty is a Family General Medical Practitioner in South-Africa, with considerable experience with the outpatient treatment of COVID-19, having treated so far nearly 8,000 patients, in his outpatient practice, without any of them requiring hospitalization or even oxygen. Dr. Chetty holds a degree in medicine and surgery and also has advanced education in genetics, advanced biology, biochemistry and microbiology. More interviews: https://covexit.com/category/videos/

(NaturalHealth365) An unprecedented number of athletes have suffered cardiac issues in 2020. Could the COVID shot program be to blame?

(NaturalHealth365) A recently published article raises the alarm about the documented mRNA jab link to heart attacks.

Nature - Clinical evidence for long-lasting immunity to SARS-CoV-2 infection

People who have had a mild case of COVID-19 are left with long-term antibody protection against future disease, according to a study from researchers at Washing

Nature - People who recover from mild COVID-19 have bone-marrow cells that can churn out antibodies for decades, although viral variants could dampen some of the protection they offer.

If you’ve had COVID-19, even a mild case, major congratulations to you as you’ve more than likely got ...

Nature - Lifetime of plasma cells in the bone marrow

Nature - SARS-CoV-2 infection induces long-lived bone marrow plasma cells that correlate with anti-SARS-CoV-2 spike protein antibody titres in individuals who have recovered from COVID-19.

The ivermectin docking we identified may interfere with the attachment of the spike to the human cell membrane. Clinical trials now underway should determine whether ivermectin is an effective treatment for SARS-Cov2 infection.

This is an evolving guide with emerging information on how to clear viral and vaccine-induced spike proteins from the body.

The recent COVID-19 pandemic is a treatment challenge in the acute infection stage but the recognition of chronic COVID-19 symptoms termed post-acute sequelae SARS-CoV-2 infection (PASC) may affect up to 30% of all infected individuals. The underlying mechanism and source of this distinct immunologic condition three months or more after initial infection remains elusive. Here, we investigated the presence of SARS-CoV-2 S1 protein in 46 individuals. We analyzed T-cell, B-cell, and monocytic subsets in both severe COVID-19 patients and in patients with post-acute sequelae of COVID-19 (PASC). The levels of both intermediate (CD14+, CD16+) and non-classical monocyte (CD14Lo, CD16+) were significantly elevated in PASC patients up to 15 months post-acute infection compared to healthy controls (P=0.002 and P=0.01, respectively). A statistically significant number of non-classical monocytes contained SARS-CoV-2 S1 protein in both severe (P=0.004) and PASC patients (P=0.02) out to 15 months post-infection. Non-classical monocytes were sorted from PASC patients using flow cytometric sorting and the SARS-CoV-2 S1 protein was confirmed by mass spectrometry. Cells from 4 out of 11 severe COVID-19 patients and 1 out of 26 also contained SARS-CoV-2 RNA. Non-classical monocytes are capable of causing inflammation throughout the body in response to fractalkine/CX3CL1 and RANTES/CCR5. Summary SARS CoV-2 S1 Protein in CD16+ Monocytes In PASC ### Competing Interest Statement B.K.P, A.P., H.R., E.L, and EBF. are employees of IncellDx

Investigation and Prosecution of Those Individuals Responsible for Crimes Against Humanity   29 September 2021     The International Criminal Court Office of the Prosecutor Post Office Box 19519 2500 CM The Hague The Netherlands     And   Ms. Karen Mosoti, or official replacement for the office of Liaison Office of the International Criminal Court to the United Nations 866 United Nations Plaza Suite 476 New York, NY, 10017 USA 212-486-1346/47/62     Email: otp.informationdesk@icc-cpi.int   Dear

Think you might be gluten sensitive? Take the quiz: https://www.glutenfreesociety.org/gluten-sensitivity-intolerance-self-test/ Hist Assist - http://glutenfreesociety.org/HistAssist While no food is guaranteed to be entirely free from histamine, there are a number of healthy gluten-free foods that are low in histamine. These include the following: - fresh meat and fish - fresh and non-citrus fruits - eggs - dairy substitutes, such as coconut milk and almond milk (choose full fat options with minimal ingredients and no additives) - fresh vegetables except tomatoes, avocados, spinach, and eggplant - Coconut and olive oil It’s important to note, however, that histamine increases as food ages. As a result, precooked and leftover foods have higher histamine levels than their fresh counterparts. To connect with Dr. Osborne visit: On the web: https://drpeterosborne.com/ Facebook: https://www.facebook.com/DoctorPeterOsborne/ Pinterest: https://www.pinterest.com/docosborne/ Instagram: https://www.instagram.com/drosborne Twitter: https://twitter.com/glutenology *These statements have not been evaluated by the Food and Drug Administration. This video is not intended to diagnose, treat, cure or prevent any disease. It is strictly intended for educational purposes only. Additionally, this information is not intended to replace the advice of your physician. Dr. Peter Osborne is one of the most sought after alternative and nutritional experts in the world. A Diplomate with the American Clinical Board of Nutrition, a graduate of Texas Chiropractic College, and a doctor of pastoral science, Dr. Osborne is one of the world’s leading authorities on gluten, nutrition, and natural health. He is the founder GlutenFreeSociety.org, one of the world's largest informational sites on gluten sensitivity. In addition, he is the author of the best selling book, No Grain No Pain, published by Touchstone (Simon & Schuster). His work has been featured by PBS, Netflix, Amazon, Fox, and many other nationally recognized outlets. For more information, visit us at https://www.glutenfreesociety.org/ or call 281-903-7527

Magnesium exhibits a range of neuronal and vascular actions that may ameliorate ischaemic CNS insults, including stroke. Significant neuroprotection with magnesium has been observed in different models of focal cerebral ischaemia in many laboratories, with infarct volume reductions between 25 and 61 …

Drinking Baking Soda as Vagal Nerve Stimulation?

Our life and health depend on having enough CO2 in the blood and tissues. Carbon dioxide is both an essential a nutrient and a product of respiration. Its lack or deficiency is a starting point for disturbances in the body up to and including cancer. The last thing a person wants is to be bicarbonate... View Article

Discover why the Shroud of Turin, one of the world’s most analyzed artifacts, is still a mystery. Join speakers Dr. Cheryl White, Russ Breault, Father Peter Mangum, and Joe Marino as they explain the secrets of the linen cloth believed by millions to be the burial shroud of Jesus of Nazareth. Copyright © 2021 Museum of the Bible. All rights reserved.

e-Sword is a feature rich and user friendly free Windows app with everything needed to study the Bible in an enjoyable and enriching manner!

NeuroMolecular Medicine - Neuroprotective, antineuroinflammatory, and proneurogenic effects of glucosamine, a naturally occurring amino sugar, have been reported in various animal models of brain...

In this study, a diabetic kidney disease model was established by placing the test rats on a high-sugar/high-fat diet combined with streptozotocin induction. Histopathological examination (H&E, Masson, and PASM stain) showed pathological changes in the diabetic rat kidneys, in addition to fibrotic symptoms and collagen deposition. Immunohistochemistry and western blot analyses indicated that the diabetic condition significantly increased the expressions of fibrotic markers including collagen, α-SMA, and fibronectin. The levels of cholesterol, triglyceride, and low-density lipoprotein were also increased in diabetic kidney disease (DKD) rat blood, while the level of high-density lipoprotein was decreased. The results of Oil red O staining experiments indicated that the kidneys of diabetic rats exhibited appreciable fat deposition, with high contents of triglyceride and cholesterol. To inhibit fibrosis and reduce fat deposition, low molecular weight fucoidan (LMWF) may be used. Based on PCR and western blot analyses, LMWF can regulate the expression levels of important lipid metabolism regulators, thereby impeding the development of kidney fibrosis. Through the vitro model, it also be indicated that LMWF could inhibit fibrosis process through regulating lipid metabolism which induced by palmitic acid.

Fucoidan is a polysaccharide found in brown alga with glorious potential for pharmacological activities, among which its anti-inflammatory properties have gained meaningful attention. Due to several advantages of formulations for topical application, this study aimed to develop and optimize a fucoidan-based cream formulation and to investigate its anti-inflammatory potential after topical application in vivo. Fucoidan from Fucus vesiculosus L. was used. The cream base consisting of olive oil and Kolliphor RH40 was optimized followed by in vitro agar diffusion and drug release studies. The fucoidan-based cream with 13% Kolliphor P 407, 1% Transcutol P, and 5% PEG400 showed good spreadability, washability, and colloidal stability, and it did not irritate the skin. The kinetics of fucoidan release from the optimized cream exhibited the best fit to the Korsmeyer–Peppas and Higuchi models with R2 > 0.99. Fucoidan release was controlled by drug diffusion and anomalous transport provided by the optimized cream base. The formulation was stable and provided high fucoidan release after storage for 1 year. Topical application of the fucoidan-based cream dose-dependently inhibited carrageenan-induced edema and ameliorated mechanical allodynia in rats. The efficacy of the fucoidan-based cream at a high dose was comparable with the efficacy of diclofenac gel. The fucoidan-based cream could be considered a promising anti-inflammatory formulation.

Background: Rheumatoid arthritis is a chronic inflammatory disease of autoimmune etiology. Current treatment includes non-steroidal anti-inflammatory drugs, selective cyclooxygenase-2 inhibitors, glucocorticoids, and disease-modifying antirheumatoid drugs, newer agents such as tumor necrosis factor-α inhibitors, and monoclonal antibodies have adverse effects such as peptic ulcer, renal toxicity, and hematological toxicity. Moreover, they are expensive when used on a long-term basis. Hence, it is necessary to find out the new cost effective as well as less toxic drug as alternative. Aim and Objective: The present study was taken up to evaluate antiarthritic activity of Aloe vera aqueous extract (AVE) in Wistar albino rats when used orally. Materials and Methods: A total 36 no. of healthy Wistar albino rats of weight 100–200 mg were used and divided into six different groups containing six rats in each. Into subplantar region of hind paw of all rats except normal control, 0.1 mL of complete Freund’s adjuvant (6 mg Mycobacterium butyricum suspended in heavy paraffin oil) was injected for induction of arthritis. The rats were treated with vehicle (gum acacia), standard drugs (indomethacin and dexamethasone) and test drug, that is, AVE 125 mg/kg, 250 mg/kg for 12 days. The rats were evaluated by measuring the % increase in paw edema volume and paw thickness (joint diameter), assessing the biophysical parameters (arthritic score), hematological parameters erythrocyte sedimentation rate, rheumatoid factor, and histopathological study of joints (arthritic index) for testing the antiarthritic potential. Results: AVE 250 mg/kg showed significant antiarthritic property as that of standard indomethacin and dexamethasone in terms of reduction in inflammation and arthritic scores. Conclusion: AVE at 250 mg/kg offered significant protection against arthritis and inflammation and can be a safer alternative for long term use.